Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’
Top Cited Papers
Open Access
- 6 August 2009
- journal article
- review article
- Published by Wiley in Parasite Immunology
- Vol. 31 (9), 560-573
- https://doi.org/10.1111/j.1365-3024.2009.01138.x
Abstract
The development of effective malaria vaccines may be hindered by extensive genetic diversity in the surface proteins being employed as vaccine antigens. Understanding of the extent and dynamics of genetic diversity in vaccine antigens is needed to guide rational vaccine design and to interpret the results of vaccine efficacy trials conducted in malaria endemic areas. Molecular epidemiological, population genetic, and structural approaches are being employed to try to identify immunologically relevant polymorphism in vaccine antigens. The results of these studies will inform choices of which alleles to include in multivalent or chimeric vaccines; however, additional molecular and immuno‐epidemiological studies in a variety of geographic locations will be necessary for these approaches to succeed. Alternative means of overcoming antigenic diversity are also being explored, including boosting responses to critical conserved regions of current vaccine antigens, identifying new, more conserved and less immunodominant antigens, and developing whole‐organism vaccines. Continued creative application and integration of tools from multiple disciplines, including epidemiology, immunology, molecular biology, and evolutionary genetics and genomics, will likely be required to develop broadly protective vaccines against Plasmodium and other antigenically complex pathogens.Keywords
This publication has 130 references indexed in Scilit:
- A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliVaccine, 2009
- Mixed allele malaria vaccines: Host protection and within-host selectionVaccine, 2008
- Profiling humoral immune responses to P. falciparum infection with protein microarraysProteomics, 2008
- Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: Implications for vaccine designProceedings of the National Academy of Sciences of the United States of America, 2008
- A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in RabbitsInfection and Immunity, 2008
- Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populationsMalaria Journal, 2007
- Structural basis of antigenic escape of a malaria vaccine candidateProceedings of the National Academy of Sciences of the United States of America, 2007
- A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivaxInfection, Genetics and Evolution, 2007
- Sequence Variation in the T-Cell Epitopes of thePlasmodium falciparumCircumsporozoite Protein among Field Isolates Is Temporally Stable: a 5-Year Longitudinal Study in Southern VietnamJournal of Clinical Microbiology, 2006
- A proteomic view of the Plasmodium falciparum life cycleNature, 2002